Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a Naarden, Netherlands-based life sciences venture capital firm with a longstanding focus on European biotechnology and biopharmaceutical development. The SPAC completed its IPO in 2021 and was structured to target acquisition opportunities in the healthcare and life sciences sector, consistent with Forbion's core investment expertise. The company filed an 8-K with the SEC on May 17, 2023, reflecting continued corporate activity during its search for a qualifying business combination. Visit SpacDesk and create a free account for complete filing histories, deal timelines, and sponsor profiles on FRBN and hundreds of other active SPACs.